Target intelligence / Profile preview

Unc-93 homolog B2 (pseudogene) (UNC93B2)

Target
UNC93B2
Molecular classification
Other
01

Overview

UNC93B2 (Unc-93 homolog B2) is classified as a pseudogene in human genomic resources and is not a functional protein-coding gene. The main functional homolog in mammals is UNC93B1, which encodes a multiple membrane-spanning endoplasmic reticulum protein involved in immune responses, particularly as a trafficking chaperone for nucleotide-sensing toll-like receptors. No activity or biological function is attributed to UNC93B2, and no evidence supports its role as a drug target or disease marker[4].

Other names
UNC93B2PUnc-93 homolog B2 (pseudogene)

Beyond the preview

Go deeper on Unc-93 homolog B2 (pseudogene) (UNC93B2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unc-93 homolog B2 (pseudogene) (UNC93B2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call